AFP 1,000 ng/mL or more and 10,000 ng/mL or less, or
hCG 5,000 IU/L or more and 50,000 IU/L or less, or
LDH 1.5 or more × N* and less than 10 × N*
13%–28% of nonseminomas
5-year PFS is 75%; 5-year survival is 80%–83%
*N indicates the upper limit of normal for the LDH assay.
Any primary site, and
Nonpulmonary visceral metastases, and
Normal AFP, any hCG, any LDH
10% of seminomas
5-year PFS is 67%; 5-year survival is 72%
Mediastinal primary, or
Nonpulmonary visceral metastases, or
For markers–any of:
AFP more than 10,000 ng/mL, or
hCG more than 50,000 IU/mL (10,000 ng/mL), or
LDH more than 10 × the upper limit of normal
16%–26% of nonseminomas
5-year PFS is 41%; 5-year survival is 71%
No patients are classified as poor prognosis.
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (2): 594-603, 1997.
van Dijk MR, Steyerberg EW, Habbema JD: Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. Eur J Cancer 42 (7): 820-6, 2006.
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Public Information from the National Cancer Institute
February 25, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this